choline has been researched along with Prodromal Characteristics in 4 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "We aimed to test whether in vivo levels of magnetic resonance spectroscopy (MRS) metabolites myo-inositol (mI), N-acetylaspartate (NAA), and choline are abnormal already during preclinical Alzheimer disease (AD), relating these changes to amyloid or tau pathology, and functional connectivity." | 7.83 | Myo-inositol changes precede amyloid pathology and relate to APOE genotype in Alzheimer disease. ( Blennow, K; Hansson, O; Minthon, L; Strandberg, O; Sundgren, PC; Voevodskaya, O; Wahlund, LO; Westman, E; Zetterberg, H, 2016) |
| "We aimed to test whether in vivo levels of magnetic resonance spectroscopy (MRS) metabolites myo-inositol (mI), N-acetylaspartate (NAA), and choline are abnormal already during preclinical Alzheimer disease (AD), relating these changes to amyloid or tau pathology, and functional connectivity." | 3.83 | Myo-inositol changes precede amyloid pathology and relate to APOE genotype in Alzheimer disease. ( Blennow, K; Hansson, O; Minthon, L; Strandberg, O; Sundgren, PC; Voevodskaya, O; Wahlund, LO; Westman, E; Zetterberg, H, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, Y | 1 |
| Kosciolek, T | 1 |
| Tang, J | 1 |
| Zhou, Y | 1 |
| Li, Z | 1 |
| Ma, X | 1 |
| Zhu, Q | 1 |
| Yuan, N | 1 |
| Yuan, L | 1 |
| Li, C | 1 |
| Jin, K | 1 |
| Knight, R | 1 |
| Tsuang, MT | 1 |
| Chen, X | 1 |
| Stromillo, ML | 1 |
| Giorgio, A | 1 |
| Rossi, F | 1 |
| Battaglini, M | 1 |
| Hakiki, B | 1 |
| Malentacchi, G | 1 |
| Santangelo, M | 1 |
| Gasperini, C | 1 |
| Bartolozzi, ML | 1 |
| Portaccio, E | 1 |
| Amato, MP | 1 |
| De Stefano, N | 1 |
| Ritchie, CW | 1 |
| Bajwa, J | 1 |
| Coleman, G | 1 |
| Hope, K | 1 |
| Jones, RW | 1 |
| Lawton, M | 1 |
| Marven, M | 1 |
| Passmore, P | 1 |
| Voevodskaya, O | 1 |
| Sundgren, PC | 1 |
| Strandberg, O | 1 |
| Zetterberg, H | 1 |
| Minthon, L | 1 |
| Blennow, K | 1 |
| Wahlund, LO | 1 |
| Westman, E | 1 |
| Hansson, O | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Study on Predictiors and Mechanism of Conversion to Psychosis in Individuals at Ultra-high Risk Group[NCT03965598] | 200 participants (Anticipated) | Observational | 2016-11-01 | Recruiting | |||
| The Swedish BioFINDER Study: Early Diagnosis of Alzheimer's Disease - a Multidisciplinary Approach[NCT01208675] | 1,150 participants (Actual) | Observational | 2010-09-30 | Active, not recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 other studies available for choline and Prodromal Characteristics
| Article | Year |
|---|---|
Gut microbiome and magnetic resonance spectroscopy study of subjects at ultra-high risk for psychosis may support the membrane hypothesis.
Topics: Adolescent; Adult; Choline; Female; Gastrointestinal Microbiome; Gyrus Cinguli; Humans; Magnetic Res | 2018 |
Brain metabolic changes suggestive of axonal damage in radiologically isolated syndrome.
Topics: Adult; Aspartic Acid; Axons; Brain; Choline; Creatine; Disease Progression; Female; Humans; Magnetic | 2013 |
Souvenaid®: a new approach to management of early Alzheimer's disease.
Topics: Alzheimer Disease; Choline; Cholinesterase Inhibitors; Disease Progression; Docosahexaenoic Acids; D | 2014 |
Myo-inositol changes precede amyloid pathology and relate to APOE genotype in Alzheimer disease.
Topics: Aged; Alzheimer Disease; Amyloidogenic Proteins; Apolipoprotein E4; Aspartic Acid; Brain; Brain Mapp | 2016 |